Dermatology CME Courses

By the end of the session the participant will be able to:

• Describe the role of the immune system in cancer and cancer therapy in metastatic melanoma.
• Distinguish between the different forms of therapy presently approved for metastatic melanoma and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
• Describe emerging (investigational) therapies for metastatic melanoma
• Describe the challenges and barriers to care associated with treating patients with metastatic melanoma

Learning Objectives:

• Summarize the most impactful findings presented at ASCO 2017 relating to Metastatic Melanoma and apply them to patient cases, taking into account any relevant barriers to care.
• Additional objectives to be dictated by clinical content

By the end of the session the participant will be able to:

• Describe the role of the immune system in cancer and cancer therapy in metastatic melanoma.
• Distinguish between the different forms of therapy presently approved for metastatic melanoma and apply them to practice, taking into account the following: treatment modalities and the recent clinical trial evidence supporting them.
• Describe emerging (investigational) therapies for metastatic melanoma
• Describe the challenges and barriers to care associated with treating patients with metastatic melanoma